協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/03/11 | 1,093 | 1,107 | 1,087 | 1,106 | +20 | +1.8% | 555,000 |
| 2014/03/10 | 1,090 | 1,105 | 1,082 | 1,086 | -18 | -1.6% | 884,000 |
| 2014/03/07 | 1,116 | 1,119 | 1,102 | 1,104 | -6 | -0.5% | 1,150,000 |
| 2014/03/06 | 1,086 | 1,116 | 1,075 | 1,110 | +24 | +2.2% | 1,271,000 |
| 2014/03/05 | 1,088 | 1,099 | 1,085 | 1,086 | +13 | +1.2% | 876,000 |
| 2014/03/04 | 1,061 | 1,083 | 1,059 | 1,073 | +3 | +0.3% | 946,000 |
| 2014/03/03 | 1,086 | 1,091 | 1,066 | 1,070 | -21 | -1.9% | 665,000 |
| 2014/02/28 | 1,101 | 1,106 | 1,085 | 1,091 | -9 | -0.8% | 660,000 |
| 2014/02/27 | 1,111 | 1,111 | 1,091 | 1,100 | -6 | -0.5% | 690,000 |
| 2014/02/26 | 1,090 | 1,110 | 1,087 | 1,106 | -1 | -0.1% | 524,000 |
| 2014/02/25 | 1,106 | 1,114 | 1,098 | 1,107 | +10 | +0.9% | 795,000 |
| 2014/02/24 | 1,079 | 1,107 | 1,077 | 1,097 | -12 | -1.1% | 1,155,000 |
| 2014/02/21 | 1,063 | 1,112 | 1,063 | 1,109 | +46 | +4.3% | 1,006,000 |
| 2014/02/20 | 1,089 | 1,090 | 1,059 | 1,063 | -10 | -0.9% | 1,098,000 |
| 2014/02/19 | 1,050 | 1,079 | 1,047 | 1,073 | +1 | +0.1% | 1,094,000 |
| 2014/02/18 | 1,045 | 1,079 | 1,045 | 1,072 | +31 | +3% | 1,050,000 |
| 2014/02/17 | 1,019 | 1,045 | 1,019 | 1,041 | +12 | +1.2% | 1,072,000 |
| 2014/02/14 | 1,048 | 1,058 | 1,024 | 1,029 | -25 | -2.4% | 1,858,000 |
| 2014/02/13 | 1,055 | 1,065 | 1,047 | 1,054 | +3 | +0.3% | 1,452,000 |
| 2014/02/12 | 1,054 | 1,060 | 1,044 | 1,051 | +7 | +0.7% | 1,117,000 |
| 2014/02/10 | 1,047 | 1,055 | 1,037 | 1,044 | +6 | +0.6% | 786,000 |
| 2014/02/07 | 1,028 | 1,042 | 1,024 | 1,038 | +27 | +2.7% | 1,219,000 |
| 2014/02/06 | 1,033 | 1,039 | 1,011 | 1,011 | -26 | -2.5% | 1,434,000 |
| 2014/02/05 | 1,032 | 1,044 | 1,023 | 1,037 | +10 | +1% | 1,567,000 |
| 2014/02/04 | 1,040 | 1,057 | 1,027 | 1,027 | -37 | -3.5% | 2,447,000 |
| 2014/02/03 | 1,037 | 1,075 | 1,036 | 1,064 | +15 | +1.4% | 1,563,000 |
| 2014/01/31 | 1,067 | 1,078 | 1,030 | 1,049 | -18 | -1.7% | 1,522,000 |
| 2014/01/30 | 1,075 | 1,075 | 1,051 | 1,067 | -29 | -2.6% | 1,355,000 |
| 2014/01/29 | 1,074 | 1,096 | 1,070 | 1,096 | +49 | +4.7% | 1,395,000 |
| 2014/01/28 | 1,038 | 1,054 | 1,038 | 1,047 | +9 | +0.9% | 961,000 |
| 2014/01/27 | 1,033 | 1,048 | 1,033 | 1,038 | -24 | -2.3% | 1,072,000 |
| 2014/01/24 | 1,080 | 1,084 | 1,055 | 1,062 | -33 | -3% | 1,757,000 |
| 2014/01/23 | 1,103 | 1,114 | 1,092 | 1,095 | -3 | -0.3% | 1,299,000 |
| 2014/01/22 | 1,090 | 1,102 | 1,084 | 1,098 | +4 | +0.4% | 1,147,000 |
| 2014/01/21 | 1,090 | 1,102 | 1,086 | 1,094 | +13 | +1.2% | 713,000 |
| 2014/01/20 | 1,086 | 1,087 | 1,078 | 1,081 | +1 | +0.1% | 562,000 |
| 2014/01/17 | 1,078 | 1,085 | 1,070 | 1,080 | -9 | -0.8% | 1,028,000 |
| 2014/01/16 | 1,099 | 1,104 | 1,085 | 1,089 | -9 | -0.8% | 831,000 |
| 2014/01/15 | 1,092 | 1,098 | 1,080 | 1,098 | +22 | +2% | 1,069,000 |
| 2014/01/14 | 1,097 | 1,100 | 1,074 | 1,076 | -51 | -4.5% | 1,669,000 |
| 2014/01/10 | 1,103 | 1,131 | 1,102 | 1,127 | +9 | +0.8% | 3,246,000 |
| 2014/01/09 | 1,120 | 1,136 | 1,112 | 1,118 | -20 | -1.8% | 1,249,000 |
| 2014/01/08 | 1,120 | 1,139 | 1,111 | 1,138 | +14 | +1.2% | 870,000 |
| 2014/01/07 | 1,128 | 1,142 | 1,123 | 1,124 | -5 | -0.4% | 1,046,000 |
| 2014/01/06 | 1,132 | 1,149 | 1,121 | 1,129 | -30 | -2.6% | 1,388,000 |
| 2013/12/30 | 1,154 | 1,159 | 1,135 | 1,159 | +16 | +1.4% | 769,000 |
| 2013/12/27 | 1,151 | 1,151 | 1,130 | 1,143 | +1 | +0.1% | 755,000 |
| 2013/12/26 | 1,138 | 1,149 | 1,131 | 1,142 | -1 | -0.1% | 780,000 |
| 2013/12/25 | 1,133 | 1,148 | 1,133 | 1,143 | -4 | -0.3% | 886,000 |
| 2013/12/24 | 1,158 | 1,160 | 1,144 | 1,147 | -5 | -0.4% | 935,000 |
2801～
2850
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
